neovii , founded in 2014 and headquartered in Rapperswil, Switzerland, is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. neovii was founded following the acquisition of Fresenius Biotech inheriting more than three decades of experience in specialty pharmaceuticals.
View Top Employees from Neovii Pharmaceuticals AGWebsite | http://www.neovii.com |
Revenue | $50.6 million |
Employees | 1 (1 on RocketReach) |
Address | 19 Zürcherstrasse, Rapperswil, Saint Gallen 8640, CH |
Phone | +41 55 210 05 00 |
Fax | +41 55 210 55 08 |
Industry | Pharmaceuticals, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 62 Companies, NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 3254 Companies, NAICS Code 325413 Companies, NAICS Code 32541 Companies, NAICS Code 621 Companies |
Looking for a particular Neovii Pharmaceuticals AG employee's phone or email?
The Neovii Pharmaceuticals AG annual revenue was $50.6 million in 2023.
1 people are employed at Neovii Pharmaceuticals AG.
Neovii Pharmaceuticals AG is based in Rapperswil, Saint Gallen.
The NAICS codes for Neovii Pharmaceuticals AG are [325, 32, 62, 6215, 62151, 3254, 325413, 32541, 621].
The SIC codes for Neovii Pharmaceuticals AG are [283, 28].